Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0025202
Disease: melanoma
melanoma
0.060 AlteredExpression disease BEFREE IFNα also induced expression of TAP1 in mouse blood and tumor tissue and suppressed the formation of melanoma metastasis in an in vivo B16 tumor model. 26735690 2016
CUI: C0025202
Disease: melanoma
melanoma
0.060 Biomarker disease BEFREE In this study, we further investigate expressions of TAP and HLA class I antigen in three human MM cell lines. pEGFP-TAP1/TAP2/TAP1+TAP2 were used to restore the expressions of TAP in the antigen presentation pathway-deficient MM cell line A375. 18385764 2008
CUI: C0025202
Disease: melanoma
melanoma
0.060 AlteredExpression disease LHGDN In this study, we further investigate expressions of TAP and HLA class I antigen in three human MM cell lines. pEGFP-TAP1/TAP2/TAP1+TAP2 were used to restore the expressions of TAP in the antigen presentation pathway-deficient MM cell line A375. 18385764 2008
CUI: C0025202
Disease: melanoma
melanoma
0.060 Biomarker disease LHGDN These results suggest that TAP1 plays an important role in the MAA-specific cytotoxic T-lymphocyte response, which has been suggested to underlie the spontaneous regression of primary melanoma. 12777979 2003
CUI: C0025202
Disease: melanoma
melanoma
0.060 AlteredExpression disease BEFREE We have addressed this question by analyzing three human melanoma cell lines with distinct phenotypes of LMP2 and TAP1 expression. 9632673 1998
CUI: C0025202
Disease: melanoma
melanoma
0.060 AlteredExpression disease BEFREE Based on our studies of in vitro established cell lines, loss of TAP1/2 or LMP2/7 expression does not appear to be a common mechanism of immune escape in malignant melanoma. 9052759 1997
CUI: C0025202
Disease: melanoma
melanoma
0.060 GeneticVariation disease BEFREE This study was designed to determine whether the adjacent upstream transporter associated with antigen processing (TAP) locus, TAP2, constitutes the centromeric boundary of disease susceptibility in melanoma. 8851724 1996